ID   UT-OC-5
AC   CVCL_A1QZ
DR   Wikidata; Q105511657
RX   CelloPub=CLPUB00591;
RX   PubMed=9888470;
RX   PubMed=10367939;
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
RX   CelloPub=CLPUB00591;
RA   Seppanen M.;
RT   "Cytokines and gynecological cancer. In vitro effects of cytokines on
RT   ovarian, endometrial and vulvar carcinoma cells.";
RL   Thesis PhD (2000); Tampere University; Tampere; Finland.
//
RX   PubMed=9888470; DOI=10.1038/sj.bjc.6690046; PMCID=PMC2362186;
RA   Engblom P.R., Rantanen V., Kulmala J., Helenius H., Grenman S.E.;
RT   "Additive and supra-additive cytotoxicity of cisplatin-taxane
RT   combinations in ovarian carcinoma cell lines.";
RL   Br. J. Cancer 79:286-292(1999).
//
RX   PubMed=10367939;
RA   Seppanen M., Henttinen T., Lin L., Punnonen J., Grenman S.E.,
RA   Punnonen R., Vihko K.K.;
RT   "Inhibitory effects of cytokines on ovarian and endometrial carcinoma
RT   cells in vitro with special reference to induction of specific
RT   transcriptional regulators.";
RL   Oncol. Res. 10:575-589(1998).
//